Due to its unique advantages, the CRISPR-Cas system has been used to perform analyte assays. CD BioSciences, a premier biotechnology company, is committed to providing you with detection method development service based on the CRISPR-Cas system.
The CRISPR-Cas system is derived from the adaptive immune system of microorganisms such as bacteria, archaea and fungi, and consists of a combination of guide RNA and Cas enzymes. As an emerging technology in the field of biomolecules, it can be used both as a gene editing tool for precise manipulation and as a sensitive and efficient analyte detection tool.
In the field of bioanalysis, some Cas proteins (Cas12, Cas13 and Cas14) have "attachment cleavage" activity, which allows non-specific cleavage of free nucleic acids in the environment, including fluorescent reporter molecules, and have been developed as efficient, fast, low-cost and highly sensitive molecular detection tools, such as CRISPR biosensors and detection kits for applications in disease diagnosis, food safety, and environmental contaminant monitoring.
Utilizing the CRISPR-Cas system's ability to specifically identify and incidentally cleave nucleic acid sequences, CD BioSciences offers detection method development service based on the CRISPR-Cas system. In addition, we also provide services for the detection of various analytes such as nucleic acids, protein biomarkers, metal ions, and small molecules.
Our DeteCasTM platform offers different services in analytes detection method development, including but not limited to the followings.
Detection Kit Development Service
Food Safety Detection
Disease Diagnosis
Environmental Monitoring
CD BioSciences provides affordable, qualified and hassle-free detection method development service based on the CRISPR-Cas system to our global clients. We guarantee on-time delivery of results. We are available to you 24 hours a day, so please feel free to contact us.
References